Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Overview
The Peripheral Artery Occlusive Disease (PAOD) clinical trial report consists of 1328 trials. The report provides an overview of the Peripheral Artery Occlusive Disease (PAOD) clinical trial scenario. Our study also includes top-line data relating to the clinical trials on Peripheral Artery Occlusive Disease (PAOD), in this report. Our analysts have further provided an overview of trial numbers and their average enrolment in top countries conducted across the globe. Furthermore, our review of the PAOD Clinical Trials landscape offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also includes the names of prominent sponsors involved with conducting the Peripheral Artery Occlusive Disease (PAOD) clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · Russia · Japan · Germany |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Bayer AG
· Sanofi · AstraZeneca Plc · Bio-Innova & Synchron Co Ltd · Eli Lilly and Co |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Peripheral Artery Occlusive Disease (PAOD) clinical trials landscape with more than 35% of the clinical trials conducted there as of November 2023
The key regions considered for Peripheral Artery Occlusive Disease (PAOD) clinical trials analysis are Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America.
In a country-wise analysis, as of November 2023, the US accounted for the highest number of Peripheral Artery Occlusive Disease (PAOD) clinical trials, followed by China and Russia.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, Germany has the highest proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular clinical trials as of November 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, Russia has the highest proportion of Peripheral Artery Occlusive Disease (PAOD) to Cardiovascular clinical trials as of November 2023.
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Peripheral Artery Occlusive Disease (PAOD) Clinical Trials
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Peripheral Artery Occlusive Disease (PAOD) clinical trials are company, institution, and government. As of November 2023, the company sponsor type dominated the Peripheral Artery Occlusive Disease (PAOD) clinical trials share, followed by institution.
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Analysis by Sponsor Types, 2023 (%)
Buy the Full Report for More Sponsor Type Insights into Peripheral Artery Occlusive Disease (PAOD) Clinical Trials
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials - Competitive Landscape
In 2023, Bayer AG conducted the highest number of Peripheral Artery Occlusive Disease (PAOD) clinical trials
A few of the leading sponsors for Peripheral Artery Occlusive Disease (PAOD) clinical trials are:
- Bayer AG
- Sanofi
- AstraZeneca Plc
- Bio-Innova & Synchron Co Ltd
- Eli Lilly and Co
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More about the Leading Players of Peripheral Artery Occlusive Disease (PAOD) Clinical Trials
Segments Covered in the Report
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Country Outlook (2023)
- The US
- China
- Russia
- Japan
- Germany
Peripheral Artery Occlusive Disease (PAOD) Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Sanofi
AstraZeneca Plc
Bio-Innova & Synchron Co Ltd
Eli Lilly and Co
Merck & Co Inc
Novartis AG
Medtronic Plc
Cook Group Inc
Johnson & Johnson
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Peripheral Artery Occlusive Disease (PAOD) clinical trials?
Asia-Pacific accounted for the highest number of Peripheral Artery Occlusive Disease (PAOD) clinical trials as of November 2023.
-
Which country conducted the highest number of Peripheral Artery Occlusive Disease (PAOD) clinical trials?
The US conducted the highest number of Peripheral Artery Occlusive Disease (PAOD) clinical trials as of November 2023.
-
Which sponsor type was the most prominent in the Peripheral Artery Occlusive Disease (PAOD) clinical trials?
Company was the most prominent sponsor type for Peripheral Artery Occlusive Disease (PAOD) clinical trials.
-
Who are the leading sponsors of Peripheral Artery Occlusive Disease (PAOD) clinical trials?
A few of the leading sponsors of Peripheral Artery Occlusive Disease (PAOD) clinical trials are Bayer AG, Sanofi, AstraZeneca Plc, Bio-Innova & Synchron Co Ltd, and Eli Lilly and Co, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.